Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity. This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes. We systematically searched the PubMed, Europe PMC and ClinicalTrials.gov database using specific keywords related to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rev Med Virol
Main Authors: Hariyanto, Timotius Ivan, Halim, Devina Adella, Rosalind, Jane, Gunawan, Catherine, Kurniawan, Andree
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209939/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.2265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados